The Oslo longitudinal recovery study

About the project

This is a research project on first-episode psychosis involving Vestre Viken Hospital Trust studying the role of neurocognition and resilience as predictors for remission and full recovery of the disorder during a 10-year follow up with annual assessments.

Objectives

Twenty-eight patients and 28 matched controls are included. The MATRICS Consensus Cognitive Battery is used to measure neurocognitive function.

Outcomes

The results may identify characteristics of persons who recover and thereby generate increased knowledge of heterogeneity in schizophrenia and the possibilities of recovery.

Background

This is an on-going research project with national and international collaborators.

Tools

Standardized clinical instruments as well as consensus based definitions of remission and full recovery are used.

Publications

Torgalsbøen, Mohn & Rund: Neurocognitive predictors of remission of symptoms and social and role functioning in the early course of first-episode schizophrenia

Published Apr. 4, 2014 4:10 PM - Last modified Apr. 11, 2014 2:17 PM